Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Ends 274 Points Lower; Dr Reddy's Laboratories and Cipla Among Top Nifty Losers
Tue, 27 Jul Closing

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Benchmark indices were caught in the global crossfire as a heavy selloff in Chinese tech giants soured sentiment in late noon deals today.

Add to it, the US markets seemed nervous ahead of the Federal Reserve's two-day monetary policy meeting that kicks off later in the day.

At the closing bell, the BSE Sensex stood lower by 274 points (down 0.5%).

Meanwhile, the NSE Nifty closed lower by 78 points (down 0.5%).

Hindalco Industries and SBI Life Insurance were among the top gainers today.

Dr Reddy's Laboratories and Cipla, on the other hand, were among the top losers today.

The SGX Nifty was trading at 15,732, down by 89 points, at the time of writing.

The BSE MidCap index ended down by 0.6%, while the BSE SmallCap index ended on a flat note today.

Sectoral indices ended on a negative note with stocks in the healthcare sector and power sector witnessing most of the selling pressure.

Metal stocks, on the other hand, witnessed buying interest.

--- Advertisement ---
21st Century's BIGGEST Revolution is Happening... Are You in?

The biggest revolution of the 21st century is Electric Vehicles.

But let me warn you that the usual way of investing in EVs may lead you to more trouble than profits.

After spending thousands of manhours on research, we've found a hidden way to profit from this EV revolution... which holds far more potential than buying regular big-name EV stocks.

And we're going to reveal it all at our exclusive online event.

Register Me for Free
------------------------------

Shares of Bajaj Finserv and Ajanta Pharma hit their respective 52-week highs today.

Asian stock markets ended on a negative note today.

The Hang Seng and the Shanghai Composite ended the day down by 4.2% and 2.5%, respectively.

The Nikkei ended up by 0.5% in today's session.

US stock futures are trading on a negative note today with the Dow Futures trading down by 153 points.

The rupee is trading at 74.46 against the US$.

Gold prices for the latest contract on MCX are trading up by 0.1% at Rs 47,500 per 10 grams.

Speaking of the stock markets, India's #1 trader, Vijay Bhambwani, shares why he is sticking to his energy trading blueprint, in his latest video for Fast Profits Daily.

Tune in here to find out more:

In news from the pharma sector, Alembic Pharma was among the top buzzing stocks today.

Shares of Alembic Pharmaceuticals dipped 11.5% to Rs 800 on the BSE in intra-day trade today after the company reported disappointing numbers for the quarter ended June 2021.

The company's consolidated profit after tax (PAT) declined 45.4% year on year (YoY) to Rs 1.6 bn on weak performance of US business.

The pharmaceutical company had posted a PAT of Rs 3 bn in the first quarter of the year 2021.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margins declined 1,258 basis points (bps) YoY to 17.8% due to higher other expenditure.

The company's revenues declined 1.1% YoY to Rs 13.3 bn with strong growth in domestic formulations being offset by a 38.1% YoY decline in US sales to Rs 3.7 bn.

Domestic formulations grew 57.2% YoY to Rs 4.81 bn.

The Rebirth of India: A Once-in-a-generation Wealth Making Opportunity Get Details Now

The acute and specialty segments grew faster than the represented pharmaceutical market, the company said.

The total expenses incurred by the company for the quarter ended 30 June 2021, stood at Rs 11.5bn. It was Rs 9.8 bn for the year-ago period.

Pranav Amin, Managing Director of Alembic Pharmaceuticals, said,

  • The India business grew exceptionally well and outpaced the industry, we hope to see this momentum continuing due to the initiatives undertaken recently.

    The US business faced price erosion due to increased competition. However, our long-term view of the US market remains intact.

Meanwhile, Alembic Pharma's research and development (R&D) spend increased by 17% during the quarter to Rs 1.7 bn, as compared to the said quarter last year.

Alembic Pharma share price ended the day down by 11.4% on the BSE.

Speaking of stocks, here is an illustration of the four phases that a stock goes through during its life cycle. The cycle repeats itself after the stock goes through all these for stages.

This cycle defines everything in markets. If you can master this cycle, then nothing can stop you from making huge profits.

If you're interested to know how a stock's life cycle can offer you the opportunity to make money in every phase, you can read about it in one of the recent editions of Profit Hunter: One Cycle That Defines Everything in the Markets

--- Advertisement ---
REVEALED: 2 Real Estate Stocks That Could Rise

Potentially 40-60% in Just 1 Year...

Here's How to Get Their Details for Free
------------------------------

Moving on to news from the IPO space...

Glenmark Life Sciences IPO Subscribed 2.21 Times on Day 1

The initial public offering (IPO) of Glenmark Life Sciences has been subscribed 2.21 times on 27 July, the first day of bidding.

The offer has received bids for 33.1 m equity shares against the IPO size of 15 m equity shares, the subscription data available on exchanges showed.

The IPO size has been reduced to 15 m equity shares after the company garnered Rs 4.5 bn from anchor investors on 26 July, a day before the opening of the issue.

The reserved portion of retail investors has already been subscribed 4.13 times and that of non-institutional investors 60%.

Qualified institutional buyers have put in bids for 7,460 equity shares against their reserved portion of 4.2 m equity shares.

The subsidiary of Glenmark Pharma plans to raise Rs 15.1 bn through the public issue which comprises a fresh issue of Rs 10.6 bn, and an offer for sale of 6.3 m equity shares by promoter.

The price band for the offer, which will close on 29 July, has been fixed at Rs 695-720 per equity share.

How the IPO sails through remains to be seen. Meanwhile, stay tuned for more updates from this space.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Sensex Ends 274 Points Lower; Dr Reddy's Laboratories and Cipla Among Top Nifty Losers". Click here!

  

Stock Market Updates

INDIAN ENERGY EXCHANGE Share Price Up by 15%; BSE POWER Index Up 1.3% (Today's Market)

Oct 19, 2021 09:30 AM

INDIAN ENERGY EXCHANGE share price is trading up by 15% and its current market price is Rs 916. The BSE POWER is up by 1.3%. The top gainers in the BSE POWER Index are INDIAN ENERGY EXCHANGE (up 15.0%) and ADANI POWER (up 10.0%). The top losers are KALPATARU POWER (down 0.5%) and POWER GRID (down 0.9%).

L&T at All Time High; BSE CAPITAL GOODS Index Up 1.8% (Today's Market)

Oct 19, 2021 09:30 AM

L&T share price has hit an all time high at Rs 1,853 (up 3.6%). The BSE CAPITAL GOODS Index is up by 1.8%. Among the top gainers in the BSE CAPITAL GOODS Index today are L&T (up 3.6%) and LAKSHMI MACHINE (up 1.1%). The top losers include BHARAT ELECTRONICS (down 0.2%) and KALPATARU POWER (down 0.5%).

HINDUSTAN COPPER Share Price Up by 6%; BSE METAL Index Up 0.3% (Today's Market)

Oct 19, 2021 09:30 AM

HINDUSTAN COPPER share price is trading up by 6% and its current market price is Rs 159. The BSE METAL is up by 0.3%. The top gainers in the BSE METAL Index is HINDUSTAN COPPER (up 6.3%). The top losers are JSW STEEL (down 0.1%) and HINDUSTAN ZINC (down 0.5%).

CYIENT Share Price Up by 5%; BSE IT Index Up 1.2% (Today's Market)

Oct 19, 2021 09:30 AM

CYIENT share price is trading up by 5% and its current market price is Rs 1,255. The BSE IT is up by 1.2%. The top gainers in the BSE IT Index are CYIENT (up 5.2%) and L&T INFOTECH (up 9.4%).

MPHASIS Share Price Up by 5%; BSE IT Index Up 1.3% (Today's Market)

Oct 19, 2021 09:28 AM

MPHASIS share price is trading up by 5% and its current market price is Rs 3,536. The BSE IT is up by 1.3%. The top gainers in the BSE IT Index are MPHASIS (up 5.3%) and L&T INFOTECH (up 9.9%).

SGX Nifty Up 77 Points, UltraTech Cement's Quarterly Performance, Deadline for AGR Dues Moratorium, and Buzzing Stocks Today (Today's Market)

Oct 19, 2021 Pre-Open

Top cues to track in today's stock market session.

View More Indian Share Market News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Oct 19, 2021 12:18 PM

MARKET STATS